Data & Technology

Four trends shaping healthcare in 2022 and beyond

How AI-powered support automation can solve the data problem in clinical trial management

A conversation with Justin Hoss, technology leader for life sciences, KPMG

AI-driven strategies for pharma brand marketing teams to help bridge the gap from data intelligence to execution

Ongoing strides in data mining, data analytics, modeling and simulation are opening up new and more definitive opportunities to apply data-driven insights to improve everything from upstream drug discovery and clinical trials, to the downstream go-to-market strategy and post-patent lifecycle management

ConvergeHEALTH Safety intended to automate pharmacovigilance case processing

Outlining the key digital trends accelerated by the transformed healthcare landscape in 2021—and their impact on pharma commercialization strategies going forward

Respondents: Pharmacies are still lagging in the compliance requirements that will be in effect in November 2023

Acquisition reportedly increases AI accessibility across life sciences organizations

As companies seek interoperability across their organizations, a joint approach to medical information and local pharmacovigilance may deliver future benefits

The pandemic has accelerated the adoption of enterprise resource planning in pharma supply chain management, as the recent US rise of one “technology enabler” attests

Using AI and data engineering insight, purchase offers customers potential to shorten clinical trials and accelerate time to commercialization

A dramatic shift to e-sampling has been the effective counter to the reduced number of rep visits to physicians’ offices

Collaboration centers around providing assistance to multiple links in the clinical trial chain, from participants to providers

Three keys to achieving digital excellence in the next normal, where a hybrid commercial model will be the standard for physician engagement

Acquisition expected to help provide customers with a quicker clinical trial recruitment process

Objective is to provide efficiency for analytics company’s medical information department

Gene therapy tech collaboration will target treatment development for Alzheimer's, Parkinson's and rare diseases

CDMO’s future greater Boston facility to expand cGMP manufacturing capacity, accelerate commercial drug supply

Report notes that companies particularly look to vendor support for technologies such as 5G, IoT, and blockchain

Deal allows CDMO to quickly expand its drug delivery technologies in the US

Aims to grow its digital clinical trial offerings internationally

Track-and-trace agreement will focus on combating product counterfeiting

Bundled $400 million acquisition provides data insights to hospitals, retail pharmacies

Exploring RCT, RWE and alternative study designs as a path forward